全文获取类型
收费全文 | 30676篇 |
免费 | 15905篇 |
国内免费 | 2篇 |
出版年
2023年 | 47篇 |
2022年 | 159篇 |
2021年 | 515篇 |
2020年 | 2240篇 |
2019年 | 3786篇 |
2018年 | 3900篇 |
2017年 | 4162篇 |
2016年 | 4210篇 |
2015年 | 4217篇 |
2014年 | 3908篇 |
2013年 | 4371篇 |
2012年 | 2082篇 |
2011年 | 1808篇 |
2010年 | 3212篇 |
2009年 | 1979篇 |
2008年 | 933篇 |
2007年 | 516篇 |
2006年 | 465篇 |
2005年 | 484篇 |
2004年 | 434篇 |
2003年 | 430篇 |
2002年 | 430篇 |
2001年 | 357篇 |
2000年 | 278篇 |
1999年 | 220篇 |
1998年 | 72篇 |
1997年 | 59篇 |
1996年 | 63篇 |
1995年 | 52篇 |
1994年 | 37篇 |
1993年 | 33篇 |
1992年 | 60篇 |
1991年 | 61篇 |
1990年 | 58篇 |
1989年 | 66篇 |
1988年 | 48篇 |
1987年 | 51篇 |
1986年 | 45篇 |
1985年 | 44篇 |
1984年 | 42篇 |
1983年 | 51篇 |
1982年 | 37篇 |
1980年 | 29篇 |
1979年 | 42篇 |
1977年 | 35篇 |
1975年 | 27篇 |
1974年 | 28篇 |
1972年 | 35篇 |
1968年 | 26篇 |
1967年 | 23篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
951.
Tracie Pennimpede Stefanie Wolter Lars Wittler Anne‐Karoline Ebert Wolfgang Rösch Raimund Stein Enrika Bartels Dominik Schmidt Thomas M. Boemers Eberhard Schmiedeke Per Hoffmann Susanne Moebus Bernhard G. Herrmann Markus M. Nöthen Heiko Reutter Michael Ludwig 《Birth defects research. Part A, Clinical and molecular teratology》2013,97(3):133-139
952.
953.
954.
955.
956.
957.
Brendan B. Larsen Lennie Chen Brandon S. Maust Moon Kim Hong Zhao Wenjie Deng Dylan Westfall Ingrid Beck Lisa M. Frenkel James I. Mullins 《PloS one》2013,8(10)
454 pyrosequencing, a massively parallel sequencing (MPS) technology, is often used to study HIV genetic variation. However, the substantial mismatch error rate of the PCR required to prepare HIV-containing samples for pyrosequencing has limited the detection of rare variants within viral populations to those present above ~1%. To improve detection of rare variants, we varied PCR enzymes and conditions to identify those that combined high sensitivity with a low error rate. Substitution errors were found to vary up to 3-fold between the different enzymes tested. The sensitivity of each enzyme, which impacts the number of templates amplified for pyrosequencing, was shown to vary, although not consistently across genes and different samples. We also describe an amplicon-based method to improve the consistency of read coverage over stretches of the HIV-1 genome. Twenty-two primers were designed to amplify 11 overlapping amplicons in the HIV-1 clade B gag-pol and env gp120 coding regions to encompass 4.7 kb of the viral genome per sample at sensitivities as low as 0.01-0.2%. 相似文献
958.
Beatriz Aldaz Ainara Sagardoy Lorena Nogueira Elizabeth Guruceaga Lara Grande Jason T. Huse Maria A. Aznar Ricardo Díez-Valle Sonia Tejada-Solís Marta M. Alonso Jose L. Fernandez-Luna Jose A. Martinez-Climent Raquel Malumbres 《PloS one》2013,8(10)
Glioblastoma multiforme (GBM)-initiating cells (GICs) represent a tumor subpopulation with neural stem cell-like properties that is responsible for the development, progression and therapeutic resistance of human GBM. We have recently shown that blockade of NFκB pathway promotes terminal differentiation and senescence of GICs both in vitro and in vivo, indicating that induction of differentiation may be a potential therapeutic strategy for GBM. MicroRNAs have been implicated in the pathogenesis of GBM, but a high-throughput analysis of their role in GIC differentiation has not been reported. We have established human GIC cell lines that can be efficiently differentiated into cells expressing astrocytic and neuronal lineage markers. Using this in vitro system, a microarray-based high-throughput analysis to determine global expression changes of microRNAs during differentiation of GICs was performed. A number of changes in the levels of microRNAs were detected in differentiating GICs, including over-expression of hsa-miR-21, hsa-miR-29a, hsa-miR-29b, hsa-miR-221 and hsa-miR-222, and down-regulation of hsa-miR-93 and hsa-miR-106a. Functional studies showed that miR-21 over-expression in GICs induced comparable cell differentiation features and targeted SPRY1 mRNA, which encodes for a negative regulator of neural stem-cell differentiation. In addition, miR-221 and miR-222 inhibition in differentiated cells restored the expression of stem cell markers while reducing differentiation markers. Finally, miR-29a and miR-29b targeted MCL1 mRNA in GICs and increased apoptosis. Our study uncovers the microRNA dynamic expression changes occurring during differentiation of GICs, and identifies miR-21 and miR-221/222 as key regulators of this process. 相似文献
959.
To investigate potential differences in stone composition with regard to the type of Primary Hyperoxaluria (PH), and in relation to the patient’s medical therapy (treatment naïve patients versus those on preventive medication) we examined twelve kidney stones from ten PH I and six stones from four PH III patients. Unfortunately, no PH II stones were available for analysis. The study on this set of stones indicates a more diverse composition of PH stones than previously reported and a potential dynamic response of morphology and composition of calculi to treatment with crystallization inhibitors (citrate, magnesium) in PH I. Stones formed by PH I patients under treatment are more compact and consist predominantly of calcium-oxalate monohydrate (COM, whewellite), while calcium-oxalate dihydrate (COD, weddellite) is only rarely present. In contrast, the single stone available from a treatment naïve PH I patient as well as stones from PH III patients prior to and under treatment with alkali citrate contained a wide size range of aggregated COD crystals. No significant effects of the treatment were noted in PH III stones. In disagreement with findings from previous studies, stones from patients with primary hyperoxaluria did not exclusively consist of COM. Progressive replacement of COD by small COM crystals could be caused by prolonged stone growth and residence times in the urinary tract, eventually resulting in complete replacement of calcium-oxalate dihydrate by the monohydrate form. The noted difference to the naïve PH I stone may reflect a reduced growth rate in response to treatment. This pilot study highlights the importance of detailed stone diagnostics and could be of therapeutic relevance in calcium-oxalates urolithiasis, provided that the effects of treatment can be reproduced in subsequent larger studies. 相似文献
960.
Zoltan Beck Linda L. Jagodzinski Michael A. Eller Doris Thelian Gary R. Matyas Anjali N. Kunz Carl R. Alving 《PloS one》2013,8(11)
Chronic HIV-1 infection is associated with persistent viremia in most patients, but it remains unclear how free virus may survive the potential hostile effects of plasma. We investigated whether sites might exist on the surfaces of circulating blood cells for protection of infectious HIV-1 particles. Red blood cells (RBC) either from blood of uninfected normal individuals, or from blood obtained without EDTA from chronically infected HIV-1 patients, invariably contained a small number of RBC having attached platelets as determined by flow cytometry, light microscopy, and immunofluorescence microscopy. After mixing normal RBC with platelet-rich plasma, discrete populations of RBC, platelets, and complexes of platelets attached to RBC were purified by fluorescence-activated cell sorting. Upon incubation of purified cells or platelets with HIV-1 followed by washing and co-incubation with CD4-positive peripheral blood mononuclear cells (PBMC), platelets, and platelet-RBC complexes, but not platelet-free RBC, caused infection of PBMC. Infection was prevented by pre-treating the platelet-RBC complexes with EDTA. Plasma and RBC (comprising a RBC/platelet-RBC mixture) from chronically infected patients with low viral loads were also co-incubated with PBMC ex vivo to determine the presence of infectious HIV-1. All freshly isolated plasmas from the HIV-1-infected donors, obtained in the absence of anticoagulant, were noninfectious. Interestingly, the RBC from most of the patients caused cell-cell infection of PBMC that was prevented by stripping the RBC with EDTA. A monoclonal antibody to DC-SIGN partially inhibited cell-cell HIV-1 infection of PBMC by normal RBC pre-incubated with platelets and HIV-1. We conclude: (a) platelet-free EDTA-free plasma from chronically infected HIV-1 patients, although containing viral RNA, is an environment that lacks detectable infectious HIV-1; (b) platelets and platelet-RBC complexes, but not purified RBC, bind infectious HIV-1; (c) DC-SIGN, and possibly other C-type lectins, may represent binding sites for infectious HIV-1 on platelets and platelet-RBC complexes. 相似文献